pain assessment
It has achieved high accuracy in predicting postoperative pain, considering blood volume change, heart rate, and blood pressure.
It will use IRIS for Health to facilitate its entry into the global hospital market.
The company has received backing from the state government of Western Australia.
The partnership leverages Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms.